Cargando…
Bioinformatic data processing pipelines in support of next‐generation sequencing‐based HIV drug resistance testing: the Winnipeg Consensus
INTRODUCTION: Next‐generation sequencing (NGS) has several advantages over conventional Sanger sequencing for HIV drug resistance (HIVDR) genotyping, including detection and quantitation of low‐abundance variants bearing drug resistance mutations (DRMs). However, the high HIV genomic diversity, unpr...
Autores principales: | Ji, Hezhao, Enns, Eric, Brumme, Chanson J., Parkin, Neil, Howison, Mark, Lee, Emma R., Capina, Rupert, Marinier, Eric, Avila‐Rios, Santiago, Sandstrom, Paul, Van Domselaar, Gary, Harrigan, Richard, Paredes, Roger, Kantor, Rami, Noguera‐Julian, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198166/ https://www.ncbi.nlm.nih.gov/pubmed/30350345 http://dx.doi.org/10.1002/jia2.25193 |
Ejemplares similares
-
Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
por: Ji, Hezhao, et al.
Publicado: (2020) -
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
por: Lee, Emma R., et al.
Publicado: (2020) -
A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance
por: Taylor, Tracy, et al.
Publicado: (2019) -
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
por: Parkin, Neil T., et al.
Publicado: (2020) -
A23 Large phylogenetic clusters highlight the HIV-1 epidemic in Canadian at risk populations
por: Capina, Rupert, et al.
Publicado: (2018)